220 related articles for article (PubMed ID: 34733840)
1. Identification and Validation of a Malignant Cell Subset Marker-Based Polygenic Risk Score in Stomach Adenocarcinoma Through Integrated Analysis of Bulk and Single-Cell RNA Sequencing Data.
Zou Q; Lv Y; Gan Z; Liao S; Liang Z
Front Cell Dev Biol; 2021; 9():720649. PubMed ID: 34733840
[No Abstract] [Full Text] [Related]
2. Integration analysis of single-cell and spatial transcriptomics reveal the cellular heterogeneity landscape in glioblastoma and establish a polygenic risk model.
Liu Y; Wu Z; Feng Y; Gao J; Wang B; Lian C; Diao B
Front Oncol; 2023; 13():1109037. PubMed ID: 37397378
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 Expressed by Tumor-Infiltrating B Cells in Gastric Cancer Related to Survival in the Tumor Microenvironment: An Analysis Combining Single-Cell RNA Sequencing with Bulk RNA Sequencing.
Su C; Yu R; Hong X; Zhang P; Guo Y; Cai JC; Hou J
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629071
[TBL] [Abstract][Full Text] [Related]
4. Single-cell data revealed CD14-type and FCGR3A-type macrophages and relevant prognostic factors for predicting immunotherapy and prognosis in stomach adenocarcinoma.
Li M; Lu M; Li J; Gui Q; Xia Y; Lu C; Shu H
PeerJ; 2024; 12():e16776. PubMed ID: 38274323
[TBL] [Abstract][Full Text] [Related]
5. The impact of the Hedgehog signal pathway on the tumor immune microenvironment of gastric adenocarcinoma by integrated analysis of scRNA-seq and RNA-seq datasets.
Zhong J; Sun Y; Wu S; Zhang T; Yang J; He Y; Liu K
Funct Integr Genomics; 2023 Aug; 23(3):258. PubMed ID: 37526746
[TBL] [Abstract][Full Text] [Related]
6. Identification of memory B-cell-associated miRNA signature to establish a prognostic model in gastric adenocarcinoma.
Liu R; Huang B; Shao Y; Cai Y; Liu X; Ren Z
J Transl Med; 2023 Sep; 21(1):648. PubMed ID: 37735667
[TBL] [Abstract][Full Text] [Related]
7. Construction of a prognostic risk model for Stomach adenocarcinoma based on endoplasmic reticulum stress genes.
Li X; Lei Y
Wien Klin Wochenschr; 2024 Jun; 136(11-12):319-330. PubMed ID: 37993598
[TBL] [Abstract][Full Text] [Related]
8. A novel risk score model for stomach adenocarcinoma based on the expression levels of 10 genes.
Guan E; Tian F; Liu Z
Oncol Lett; 2020 Feb; 19(2):1351-1367. PubMed ID: 31966067
[TBL] [Abstract][Full Text] [Related]
9. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
Zhou R; Peng N; Li W
Front Immunol; 2022; 13():964919. PubMed ID: 36059494
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Novel Prognosis Prediction Model for Patients With Stomach Adenocarcinoma.
Wang T; Wen W; Liu H; Zhang J; Zhang X; Wang Y
Front Med (Lausanne); 2021; 8():793401. PubMed ID: 35004767
[No Abstract] [Full Text] [Related]
11. Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma.
Jiang A; Wang J; Liu N; Zheng X; Li Y; Ma Y; Zheng H; Chen X; Fan C; Zhang R; Fu X; Yao Y
Front Genet; 2022; 13():833797. PubMed ID: 35154287
[No Abstract] [Full Text] [Related]
12. Development of a novel copper metabolism-related risk model to predict prognosis and tumor microenvironment of patients with stomach adenocarcinoma.
Sun D; Zhang H; Zhang C
Front Pharmacol; 2023; 14():1185418. PubMed ID: 37284310
[No Abstract] [Full Text] [Related]
13. Development of a prognostic metabolic signature in stomach adenocarcinoma.
Gong Y; Wu S; Dong S; Chen S; Cai G; Bao K; Yang H; Jiao Y
Clin Transl Oncol; 2022 Aug; 24(8):1615-1630. PubMed ID: 35355155
[TBL] [Abstract][Full Text] [Related]
14. Identification of Transcriptional Heterogeneity and Construction of a Prognostic Model for Melanoma Based on Single-Cell and Bulk Transcriptome Analysis.
Kang Z; Wang J; Huang W; Liu J; Yan W
Front Cell Dev Biol; 2022; 10():874429. PubMed ID: 35646893
[TBL] [Abstract][Full Text] [Related]
15. A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma.
Ye Z; Zheng M; Zeng Y; Wei S; Huang H; Wang Y; Liu Q; Lin Z; Chen S; Zheng Q; Chen L
Front Oncol; 2021; 11():612952. PubMed ID: 34235071
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of nicotinamide adenine dinucleotide (NAD
Cai L; Ke C; Lin Z; Huang Y; Wang A; Wang S; Chen C; Zhong C; Fu L; Hu P; Chai J; Zhang H; Zhang B
J Gastrointest Oncol; 2022 Dec; 13(6):2845-2862. PubMed ID: 36636067
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis indicates the potential values of ANKRD53 in stomach adenocarcinoma.
Jin C; Lu X; Yang M; Hou S
Discov Oncol; 2024 May; 15(1):188. PubMed ID: 38801557
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach Adenocarcinoma.
Luo N; Fu M; Zhang Y; Li X; Zhu W; Yang F; Chen Z; Mei Q; Peng X; Shen L; Zhang Y; Li Q; Hu G
Front Cell Dev Biol; 2022; 10():935135. PubMed ID: 35859893
[TBL] [Abstract][Full Text] [Related]
19. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
[TBL] [Abstract][Full Text] [Related]
20. Machine learning-based cell death signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinoma.
Li F; Feng Q; Tao R
Medicine (Baltimore); 2024 Mar; 103(10):e37314. PubMed ID: 38457593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
